SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000880771-16-000148
Filing Date
2016-06-15
Accepted
2016-06-15 12:35:01
Documents
2
Period of Report
2016-06-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K scln-20160615x8k.htm 8-K 100374
2 EX-10.1 scln-20160615xex10_1.htm EX-10.1 279969
  Complete submission text file 0000880771-16-000148.txt   381660
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19825 | Film No.: 161714818
SIC: 2834 Pharmaceutical Preparations